Dabigatran Compared With Warfarin for Stroke Prevention With Atrial Fibrillation: Experience in Hong Kong

BACKGROUND: Dabigatran is an oral direct thrombin inhibitor recently approved for stroke prevention in atrial fibrillation (AF) as an alternative to warfarin. The primary advantages of dabigatran are freedom from monitoring and less interaction with other drugs and food. It is ideal for patients who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Cardiol
Hauptverfasser: Ho, Jason C. S., Chang, Andy M., Yan, Bryan P., Yu, Cheuk Man, Lam, Yat Yin, Lee, Vivian W. Y.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wiley Periodicals, Inc. 2012
Schlagworte:
Clinical Investigations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652425/
https://ncbi.nlm.nih.gov/pubmed/23108916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22069
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge